Stem Cells USA & Regenerative Medicine Congress is North America’s largest commercial stem cells and regenerative medicine conference

The Stem Cells USA & Regenerative Medicine Congress is where science and business come together to advance the commercialization of stem cells and regenerative medicine. Speakers include senior director-level executives from pharmaceutical companies, biotechnology companies, government agencies, and private equity and venture capital firms.

The Stem Cells USA & Regenerative Medicine Congress is part of Terrapinn’s successful portfolio of globally renowned life science events. Terrapinn’s Stem Cells & Regenerative Medicine brand has an established track record in the USA, Europe and Asia.

 
Stem Cells USA & Regenerative Medicine Congress is North America's largest commercial stem cells and regenerative medicine conference 
 
 
 Stem Cells USA & Regenerative Medicine Congress has a track record of success

Don't just take our word for it 

“The conference was actually one of the best I’ve attended and participated in. The longer sessions provide time for valuable discussion from the panel and audience. Thanks again, and I’d be delighted to participate in future Terrapinn meetings.”
Liz Bui, IP Counsel and Director, Corporate Development, ViaCyte

“This was one of the best organized conferences of the year – great job!”
Karl Groth, Chairman and Chief Executive Officer, Bioheart, Inc.

 
sponsorship opportunities at Stem Cells USA & Regenerative Medicine Congress speaking opportunities at Stem Cells USA & Regenerative Medicine Congress

download the Stem Cells USA & Regenerative Medicine Congress brochure register for Stem Cells USA & Regenerative Medicine Congress now
 

Come to the Stem Cells USA &
Regenerative Medicine Congress and learn:

  • How to optimize clinical development of cell-based therapies
  • How to overcome strategic and regulatory challenges
  • How to negotiate reimbursement
  • How to navigate funding and partnership opportunities
  • How to implement stem cell platforms into drug discovery

Who should attend the Stem Cells USA & Regenerative Medicine Congress:

  • Big pharma
  • Biotechs
  • Investors
  • Academics and research institutions
  • Government agencies
  • CROs
  • CMOs
  • Technology providers
  • Other service providers

The Stem Cells USA & Regenerative Medicine Congress focus:

  • Cord blood banking & therapeutics
  • Funding & partnerships
  • Big pharma progress
  • Drug discovery
  • Overcoming regulatory hurdles
  • Commercialization & reimbursement
  • Introducing RM into healthcare

If you need to know the latest innovations in these areas you must attend.

 

Co-located events:

  • World Cord Blood Congress

news